Keywords: Spectrum Pharma, Alloss Therapeutics, Tender offer extension, Folotyn, Lymphoma

Spectrum extends tender offer for Allos

Article | 09 July 2012

Print This

US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) said late Friday that it has again extended tender offer to purchase all ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in